☰

Vinod Chaudhary, Ph.D. - Publications

Affiliations: 
2013 Chemistry Brigham Young University, Provo, UT, United States 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Chaudhary V, Albacker LA, Deng S, Chuang YT, Li Y, Umetsu DT, Savage PB. Synthesis of fungal glycolipid asperamide B and investigation of its ability to stimulate natural killer T cells. Organic Letters. 15: 5242-5. PMID 24111801 DOI: 10.1021/Ol4024375  0.472
2013 Albacker LA, Chaudhary V, Chang YJ, Kim HY, Chuang YT, Pichavant M, DeKruyff RH, Savage PB, Umetsu DT. Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nature Medicine. 19: 1297-304. PMID 23995283 DOI: 10.1038/Nm.3321  0.474
2013 Gu X, Jennings JD, Snarr J, Chaudhary V, Pollard JE, Savage PB. Optimization of ceragenins for prevention of bacterial colonization of hydrogel contact lenses. Investigative Ophthalmology & Visual Science. 54: 6217-23. PMID 23970466 DOI: 10.1167/Iovs.13-12664  0.438
2012 Williams DL, Haymond BS, Beck JP, Savage PB, Chaudhary V, Epperson RT, Kawaguchi B, Bloebaum RD. In vivo efficacy of a silicone‒cationic steroid antimicrobial coating to prevent implant-related infection. Biomaterials. 33: 8641-56. PMID 22940221 DOI: 10.1016/J.Biomaterials.2012.08.003  0.417
2012 Pollard JE, Snarr J, Chaudhary V, Jennings JD, Shaw H, Christiansen B, Wright J, Jia W, Bishop RE, Savage PB. In vitro evaluation of the potential for resistance development to ceragenin CSA-13. The Journal of Antimicrobial Chemotherapy. 67: 2665-72. PMID 22899801 DOI: 10.1093/Jac/Dks276  0.442
2012 Bai L, Picard D, Anderson B, Chaudhary V, Luoma A, Jabri B, Adams EJ, Savage PB, Bendelac A. The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. European Journal of Immunology. 42: 2505-10. PMID 22829134 DOI: 10.1002/Eji.201242531  0.454
Show low-probability matches.